INS and liver disorder: Induced higher insulin sensitivity and glucose tolerance.Reduced hepatic glycogen synthesis, which may be due to inhibition of gluconeogenesis.Changes in levels of centrally circulating proteins (including proteins that may be associated with diabetes and liver disease).